Sep 2026· Proteomics· pp.
e70179
· 1 citation· 39 references
Medicine
Abstract
Chemoproteomics aims to achieve precise and comprehensive quantification of protein-small molecule interactions, yet methodological comparisons across quantitative proteomics workflows remain scarce. Here, we systematically benchmark tandem mass tag data-dependent acquisition (TMT-DDA) on Orbitrap Exploris/Eclipse instruments against label-free data-independent acquisition parallel accumulation-serial fragmentation (LFQ-diaPASEF) on a timsTOF Pro 2 mass spectrometer when applied for 2-dimensional thermal proteome profiling (2D-TPP) and Kinobeads-based chemoproteomics. Our findings demonstrate that TMT-DDA provided more confident detection of compound-induced thermal shifts despite having lower proteome coverage in high-complexity 2D-TPP datasets. In contrast, LFQ-diaPASEF excelled in low-complexity affinity enrichment experiments, achieving up to 63% broader total proteome coverage and comparable quantitative accuracy, even with ultra-short gradients. Additionally, we show that normalization strategies in DIA require careful selection to avoid artifacts when transforming IC50s into apparent dissociation constants (Kd apps). These findings emphasize that the trade-offs inherent to each platform critically impact chemoproteomics experiments and that instrument-method pairings should be selected based on experimental complexity, quantitative precision, data completeness needs, and throughput demands.
A sample-aware diaPASEF method optimization strategy for a timsTOF platform that demonstrates the most substantial impact on low-abundance proteins and provides an opportunity for a more precise and comprehensive analysis of the biological functions of biomarkers.
J. Rijal, Imane Charmarke Askar, Aurélie Hirschler et al.· Analytical Chemistry· 0 citations
This review summarizes the evolution, principles, workflows, strengths, limitations, and representative applications of MS, SomaScan, Olink PEA, and Nautilus Voyager, and discusses their integration in biomarker discovery, population proteomics, and precision medicine.
Dimitra Papatziamou, A. Singh, Mehul V. Makwan et al.· Biochimica et Biophysica Act...· 0 citations
Improvements enabling quantification of site-specific modifications, including post-translational modifications and covalent compound-protein interactions spanning diverse pathways are described.
Steven R. Shuken, Geordon A. Frere, Charlotte R. Beard et al.· Nature Communications· 0 citations
This first study to include Olink Reveal in a systematic cross-platform comparison and to directly compare the Orbitrap Astral with the previous-generation Orbitrap Exploris 480 under identical conditions provides a concrete, evidence-based framework for workflow selection and support the co-deployment of deep MS and h...
Jean-Marc Monneuse, Hayat Hage, Célie Da Silva et al.· Journal of Proteomics· 0 citations
The discovery of alternative proteins (AltProts), translated from non-canonical ORFs, has expanded the human proteome and revealed a hidden layer known as the “ghost proteome”. Despite increasing evidence, AltProts detection remains challenging due to their small size, physicochemical heterogeneity, and lack of annotat...
A. Montero-Calle, A. Peláez-García, A. J. Martín-Galiano et al.· bioRxiv· 0 citations
ProteoformTracker is an online web tool that prospectively models MS signal and evaluates the feasibility of using TDP/MDP to distinguish a target proteoform from related isoforms and the background proteome, and envisioned as a useful tool for users to plan TDP/MDP experiments targeting specific proteoforms.
Araf Mahmud, Zhi-Hao Zhang, Si Wu et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.